Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.10−0.20 (-0.86%)
Close on Nov 17, 2026Market cap $462.26MP/E –Yield –
Neurogene profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Neurogene's profit margin for the twelve months ending Dec 31, 2024 was -8123.7%. For fiscal 2024 it was -8123.7%, against -126.3% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -8123.7% | −7997.3 |
| FY2018 | Dec 31, 2018 | -126.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -1999.1% | – |
| Q2 FY2018 | Jun 30, 2018 | 11.7% | – |
See a number that looks wrong?